In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
The US Agency for International Development is celebrating the role of science and innovation in improving global health from May 1-10.
The Drugs for Neglected Diseases initiative (DNDi) was selected as one of two finalists for the Rockefeller Foundation's "Next Century Innovators Award." DNDi was chosen from among 1,000 nominations for its innovative approach to research and development to address the urgent health needs of the world's most neglected and vulnerable people.
The National Institute of Allergy and Infectious Diseases has announced that a clinical trial, called HVTN 505, evaluating a two-part HIV vaccine candidate has been halted.
The GHTC recently released the Global Health Regulatory Requirements Database, a unique resource designed to help researchers and regulatory professionals access needed information to secure approval to conduct clinical trials and market products.
Rep. Gerry Connolly (D-VA) has introduced the Global Partnerships Act of 2013, which would overhaul the Foreign Assistance Act of 1961 and make US foreign assistance more efficient and effective.